CLL

patient care perspectives

by Susan O’Brien, MD

Many patients with newly diagnosed chronic lymphocytic leukemia (CLL) do not require treatment initially, and some may never require treatment at a......READ MORE

patient care perspectives

by John C. Byrd, MD

Our featured expert describes several points that may help patients appreciate the rationale for the deferred treatment of early stage, asymptomati......READ MORE

patient care perspectives

by John C. Byrd, MD

Bruton tyrosine kinase (BTK) inhibitor therapies have revolutionized the treatment of patients with chronic lymphocytic leukemia (CLL). Our feature......READ MORE

patient care perspectives

by Ian W. Flinn, MD, PhD

The immune impairments of chronic lymphocytic leukemia (CLL) generally worsen over time, so early vaccination is encouraged. All CLL treatments may......READ MORE

patient care perspectives

by Ian W. Flinn, MD, PhD

Venetoclax-plus-obinutuzumab combination therapy can provide patients with chronic lymphocytic leukemia (CLL) with an option for fixed-duration tre......READ MORE